Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther financing activitiesSales of Property, Plant and EquipmentShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Senti Biosciences (SNTI) Net Income (2021 - 2025)

Senti Biosciences has reported Net Income over the past 4 years, most recently at -$18.5 million for Q4 2025.

  • Quarterly results put Net Income at -$18.5 million for Q4 2025, changed N/A from a year ago — trailing twelve months through Dec 2025 was -$67.9 million (changed N/A YoY), and the annual figure for FY2025 was -$67.9 million, changed.
  • Net Income for Q4 2025 was -$18.5 million at Senti Biosciences, down from -$16.8 million in the prior quarter.
  • Over the last five years, Net Income for SNTI hit a ceiling of $21.7 million in Q3 2023 and a floor of -$21.7 million in Q2 2022.
  • Median Net Income over the past 4 years was -$8.8 million (2021), compared with a mean of -$7.8 million.
  • Biggest five-year swings in Net Income: crashed 997692.87% in 2022 and later soared 1028.2% in 2023.
  • Senti Biosciences' Net Income stood at -$3.9 million in 2021, then plummeted by 121.54% to -$8.5 million in 2022, then surged by 99.67% to -$28000.0 in 2023, then tumbled by 66110.71% to -$18.5 million in 2025.
  • The last three reported values for Net Income were -$18.5 million (Q4 2025), -$16.8 million (Q3 2025), and -$16.5 million (Q2 2025) per Business Quant data.